<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yuan J</submitter><funding>the Sichuan Province Science and Technology Department Project</funding><funding>National Natural Science Foundation of China</funding><funding>the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University</funding><pagination>4727</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9563307</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(19)</volume><pubmed_abstract>The serine/arginine-rich splicing factors (SRSF)-mediated alternative splicing plays an essential role in the occurrence and progression of hepatocellular carcinoma (HCC). However, the SRSF-based signature that can predict the prognosis and therapy efficiency is yet to be investigated in HCC. Here, we comprehensively assessed the landscape and prognostic significance of the SRSF family genes in HCC. Then, we screened the SRSF family-related genes for signature construction and explored their biological characteristics. We further established an SRSF score consisting of 18 SRSF-associated genes and evaluated its correlation with prognosis and drug sensitivity in HCC. The predictive power of the SRSF score was validated in independent HCC cohorts and different HCC subgroups. Moreover, we fur</pubmed_abstract><journal>Cancers</journal><pubmed_title>Comprehensive Molecular Analysis Identified an SRSF Family-Based Score for Prognosis and Therapy Efficiency Prediction in Hepatocellular Carcinoma.</pubmed_title><pmcid>PMC9563307</pmcid><funding_grant_id>82070674</funding_grant_id><funding_grant_id>ZY2017308</funding_grant_id><funding_grant_id>2019YFG0036</funding_grant_id><pubmed_authors>Wu Z</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Lv T</pubmed_authors><pubmed_authors>Yuan J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comprehensive Molecular Analysis Identified an SRSF Family-Based Score for Prognosis and Therapy Efficiency Prediction in Hepatocellular Carcinoma.</name><description>The serine/arginine-rich splicing factors (SRSF)-mediated alternative splicing plays an essential role in the occurrence and progression of hepatocellular carcinoma (HCC). However, the SRSF-based signature that can predict the prognosis and therapy efficiency is yet to be investigated in HCC. Here, we comprehensively assessed the landscape and prognostic significance of the SRSF family genes in HCC. Then, we screened the SRSF family-related genes for signature construction and explored their biological characteristics. We further established an SRSF score consisting of 18 SRSF-associated genes and evaluated its correlation with prognosis and drug sensitivity in HCC. The predictive power of the SRSF score was validated in independent HCC cohorts and different HCC subgroups. Moreover, we fur</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-19T06:47:51.66Z</modification><creation>2025-04-19T06:47:51.66Z</creation></dates><accession>S-EPMC9563307</accession><cross_references><pubmed>36230650</pubmed><doi>10.3390/cancers14194727</doi></cross_references></HashMap>